NY Post: FDA approves system to warn doctors before coronavirus patients deteriorate

The hospital system made by CLEW — a company based in Netanya that predicts life-threatening medical complications — has helped to keep the computer and telemedicine networks at two major Israeli hospitals running during the coronavirus pandemic, the Times of Israel reported. from NY Post: FDA approves system to warn doctors before coronavirus patients deteriorate

ILTV: Interview with CLEW’s CEO, Gal Salomon

CLEW Receives FDA Emergency Use Authorization (EUA) for Its Predictive Analytics Platform in Support of COVID-19 Patients. CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19. from ILTV: Interview with CLEW’s CEO, Gal Salomon

CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients

CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19 from CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients

nocamels: AI Medical Analytics Startup CLEW Gets Emergency FDA Nod For COVID-19 Solution

Israeli medical analytics startup Clew announced on Tuesday that it received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its ICU solution, which allows healthcare providers to help identify patients at risk of being diagnosed with respiratory failure or hemodynamic instability, two common complications associated with COVID-19. from nocamels: AI Medical Analytics Startup CLEW Gets Emergency FDA Nod For COVID-19 Solution

Request a Demo

"*" indicates required fields

Name*